C. Cotrutz
Papers
13
Total Citations
231
H-Index
6
About
C. Cotrutz is a radiation oncology researcher whose work has significantly advanced the field of stereotactic body radiation therapy (SBRT) and radiosurgery across multiple disease sites. With a career spanning more than two decades, Cotrutz has made particularly notable contributions to the treatment of prostate cancer using extreme hypofractionation, co-authoring landmark multicenter trials that helped establish SBRT as a safe and effective approach for low- and intermediate-risk disease. The 2018 multicenter trial on prostate SBRT survival and toxicity outcomes has garnered 128 citations, underscoring its influence on clinical practice and treatment guidelines. Beyond prostate cancer, Cotrutz has explored innovative applications of radiosurgery for trigeminal neuralgia using frameless CyberKnife systems, early-stage breast cancer, and inoperable lung tumors through phase I dose escalation studies. His research consistently emphasizes patient-reported quality of life alongside clinical endpoints, reflecting a commitment to patient-centered care. Collectively, his body of work has helped validate hypofractionated and stereotactic approaches that are now increasingly central to modern radiation oncology, making his contributions essential reading for clinicians and researchers entering the field.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10